Updated Date:
27 Jan 2026
Product Detail:
SALBUTAMOL CIPLA salbutamol 5mg/2.5mL (as sulfate) inhalation ampoules
Shortage Status:
Current
AUST R:
115657
Availability:
Unavailable
Active Ingredient:
salbutamol sulfate
Reason:
Manufacturing
Dosage Form:
Inhalation,conventional
Supply Impact Dates
From 17 Mar 2025
To 31 Mar 2026
Management Action:
An overseas registered product has been approved for supply under Section 19A. See the website and search for the active ingredient: https://www.tga.gov.au/resources/section-19a-approvals
